Phreesia, Inc. (NYSE:PHR) Shares Acquired by Rhumbline Advisers

Rhumbline Advisers raised its holdings in shares of Phreesia, Inc. (NYSE:PHR) by 1.0% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 82,136 shares of the company’s stock after acquiring an additional 853 shares during the quarter. Rhumbline Advisers owned approximately 0.14% of Phreesia worth $1,741,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. nVerses Capital LLC lifted its holdings in shares of Phreesia by 76.5% in the 2nd quarter. nVerses Capital LLC now owns 3,000 shares of the company’s stock valued at $64,000 after purchasing an additional 1,300 shares during the last quarter. Russell Investments Group Ltd. raised its stake in Phreesia by 5,462.3% during the 4th quarter. Russell Investments Group Ltd. now owns 3,838 shares of the company’s stock valued at $89,000 after acquiring an additional 3,769 shares during the last quarter. EntryPoint Capital LLC purchased a new stake in Phreesia during the 1st quarter valued at approximately $169,000. Quadrature Capital Ltd purchased a new stake in Phreesia during the 1st quarter valued at approximately $202,000. Finally, ProShare Advisors LLC increased its position in Phreesia by 8.6% during the 1st quarter. ProShare Advisors LLC now owns 9,522 shares of the company’s stock worth $228,000 after purchasing an additional 751 shares during the period. 92.10% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CFO Balaji Gandhi sold 3,502 shares of Phreesia stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $23.25, for a total value of $81,421.50. Following the completion of the transaction, the chief financial officer now directly owns 98,578 shares in the company, valued at $2,291,938.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Phreesia news, CFO Balaji Gandhi sold 3,502 shares of Phreesia stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $23.25, for a total value of $81,421.50. Following the completion of the transaction, the chief financial officer now directly owns 98,578 shares in the company, valued at $2,291,938.50. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, General Counsel Allison C. Hoffman sold 14,110 shares of Phreesia stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $26.03, for a total value of $367,283.30. Following the completion of the transaction, the general counsel now owns 121,003 shares of the company’s stock, valued at $3,149,708.09. The disclosure for this sale can be found here. Over the last three months, insiders sold 46,203 shares of company stock worth $1,129,699. Corporate insiders own 5.80% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on PHR shares. KeyCorp lowered their price target on Phreesia from $27.00 to $25.00 and set an “overweight” rating on the stock in a report on Thursday, July 11th. Royal Bank of Canada reissued a “sector perform” rating and set a $23.00 price target on shares of Phreesia in a research note on Thursday, September 5th. Canaccord Genuity Group reissued a “buy” rating and set a $34.00 price target on shares of Phreesia in a research note on Thursday, September 5th. Truist Financial increased their target price on Phreesia from $29.00 to $31.00 and gave the stock a “buy” rating in a research report on Friday, September 6th. Finally, Robert W. Baird increased their target price on Phreesia from $31.00 to $34.00 and gave the stock an “outperform” rating in a research report on Friday, September 6th. One investment analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat.com, Phreesia presently has an average rating of “Moderate Buy” and a consensus price target of $29.42.

Phreesia Stock Down 0.8 %

Shares of Phreesia stock opened at $23.56 on Friday. The company has a market capitalization of $1.36 billion, a PE ratio of -10.86 and a beta of 0.93. Phreesia, Inc. has a 1-year low of $12.05 and a 1-year high of $29.16. The business has a 50-day moving average of $24.09 and a 200-day moving average of $22.72. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.77 and a quick ratio of 1.77.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.